Issue Understanding The Industry Dynamics

Current Issue: Q1 2020

The Executive Issue

Understanding The Industry Dynamics

Our first quarter edition features leading insights from subject matter experts covering a range of scientific topics, including the growth of the microbiome field, advanced therapies, epigenetics, RNA biomarkers for cancer, drug delivery via silica nanoparticles, artificial intelligence, and the path to wellness through cannabis.

Also In This Issue

Innovation

A Chance to Invest or Present at the Yale Innovation Summit

Taking place on May 13, 2020, the Yale Innovation Summit is an opportunity to learn about advancements in the industry, pitch new ideas, and invest. Over 1,000 attendees, 200 corporations, and 100 investment firms are expected at the summit, where more than $2 million will be awarded in investment prizes. The event will also feature […]

Pharmaceutics Know-How

Pharmaceutics Know-How and Service Excellence to Re-Energize a CDMO

INDUSTRY LEADER INSIGHT: Pharmaceutics International, Inc. (Pii) Pharmaceutics International, Inc., otherwise known as Pii, is reemerging as a customer-focused market-leading contract development and manufacturing organization (CDMO). The company is undergoing a transformation, returning to our deep and established roots as a provider of contract development and manufacturing services and leveraging our unparalleled scientific insight and […]

AAV Vector Production

Challenges to Process Validation for Viral Vectors

Process validation is essential for ensuring robust, reliable processes that can produce high-quality viral vector products. Many challenges remain in implementing effective process validation strategies for these highly complex biomolecules. The Process is the Product Owing to the complexity of viral vector products, which comprise multiple proteins and nucleic acids, it is not possible to […]

CDMO Leadership

A Vision for Achieving Worldwide Biopharmaceutical CDMO Leadership

With the biopharmaceutical industry undergoing significant transformation, it is essential that CDMOs evolve to meet the changing needs of their clients. As a privately owned company with a long-term view and a commitment to building a sustainable business, Rentschler Biopharma SE has taken the time to gather external insights into trends and issues in the […]

Excipients

New Mannitol Formulations Are a Gem of a Collection

As a pharmaceutical excipient, mannitol imparts attractive mouthfeel, but mannitol products on the market have limited use owing to poor tabletability properties. New technology developed by SPI Pharma has enabled the production of mannitol grades with superior binding and quick disintegration, resulting in better tabletability. With these new mannitol grades, it is possible to increase […]

Virtual Panel

Leveraging a Biomanufacturing Legacy to Support New Business

VIRTUAL PANEL: Grifols Recombinant Protein Contract Development and Manufacturing Organization (CDMO) has three decades of experience manufacturing recombinant proteins. Recently, the business expanded its focus to apply its experience to producing therapeutic proteins for biopharmaceutical organizations. Its new GMP consolidated manufacturing facility (CMF) on its Emeryville, California, campus supports this expansion. The CMF facility houses […]

Business Models

CDMO Services Designed to Support Evolving Pharma Business Models

Pharmaceutical companies have a responsibility to guarantee both the supply of high-quality medicines and the safety of their personnel. Next-generation pharmaceutical innovation is facilitated by collaboration with service providers with operational and regulatory experience and the right people, processes, and policies to improve productivity and efficiency while reducing costs and environmental impacts. Critical to the […]

Past Issues

View all Past Issues

The Outsourcing Issue

View Issue »

Issue #3 | Volume #6 | Q3 2020

The Executive Issue

View Issue »

Issue #1 | Volume #4 | Q1 2018

Market Landscape

View Issue »

Issue #1 | Volume #3 | Q1 2017

The Innovation Issue

View Issue »

Issue #4 | Volume #4 | Q4 2018